Prognostic factors for survival of stage
✍
S.-H. Ignatius Ou; Jason A. Zell; Argyrios Ziogas; Hoda Anton-Culver
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 180 KB
👁 1 views
## Abstract ## BACKGROUND. Platinum‐based adjuvant chemotherapy in randomized trials has failed to provide a survival benefit in patients with resected stage I nonsmall cell lung cancer (NSCLC). Using data from the California Cancer Registry (CCR), we explored factors that had detrimental effects